Posted by Michael Wonder on 08 Mar 2022
FDA offers funding for biosimilar regulatory science pilot
7 March 2022 - The US FDA is offering funding for several research proposals under the regulatory science pilot for biosimilars under the upcoming Biosimilar User Fee Amendments program, with a $5 million funding opportunity announced on Monday.
The agency and industry agreed to fund the regulatory science pilot during the negotiations for the third iteration of the agency’s biosimilar review program.
